Data processing: measuring – calibrating – or testing – Measurement system in a specific environment – Biological or biochemical
Reexamination Certificate
2011-01-11
2011-01-11
Noakes, Suzanne M. (Department: 1656)
Data processing: measuring, calibrating, or testing
Measurement system in a specific environment
Biological or biochemical
C703S011000
Reexamination Certificate
active
07869958
ABSTRACT:
The present invention relates to a method for identifying modulators of B1 G-protein coupled receptors. The present invention also relates to a method for identifying an antagonist or agonist of the corticotropin-releasing factor receptor 2 (CRFR2). The present invention also relates to a method for improving antagonists or agonists of CRFR2. The present invention also relates to the three-dimensional structure of CRFR2 as representative of the B1 GPCR subfamily and its use as a basis for rational drug design of antagonist or agonists of B1 GPCRs.
REFERENCES:
patent: 4282287 (1981-08-01), Giese
patent: 4542102 (1985-09-01), Dattagupta et al.
patent: 4612132 (1986-09-01), Wollenberg et al.
patent: 4812128 (1989-03-01), Mikelsaar
patent: 4906122 (1990-03-01), Barrett et al.
patent: 5030103 (1991-07-01), Buist et al.
patent: 5252743 (1993-10-01), Barrett et al.
patent: 5583973 (1996-12-01), DeLisi et al.
patent: 5612894 (1997-03-01), Wertz
patent: 5643873 (1997-07-01), Barrett et al.
patent: 5654276 (1997-08-01), Barrett et al.
patent: 6080576 (2000-06-01), Zambrowicz et al.
patent: 6093573 (2000-07-01), Beamer et al.
patent: 6348466 (2002-02-01), Haddach et al.
patent: 6500839 (2002-12-01), Haddach et al.
patent: 6514982 (2003-02-01), Haddach et al.
patent: 6531475 (2003-03-01), Haddach et al.
patent: 6541469 (2003-04-01), Haddach
patent: 6583143 (2003-06-01), Haddach
patent: 6664261 (2003-12-01), Chen et al.
patent: 6747034 (2004-06-01), Haddach et al.
patent: 84/03564 (1984-09-01), None
patent: 90/07582 (1990-07-01), None
patent: 91/00868 (1991-01-01), None
patent: 91/07087 (1991-05-01), None
Goodsell et al., Journal of Molecular Recognition, 1996, vol. 9, pp. 1-5.
Böhm et al., Journal of Computer-Aided Molecular Design, 1996, vol. 10, pp. 265-272.
McPherson, A. Current Approaches to Macromolecular Crystallization. European Journal of Biochemistry. 1990. vol. 189, pp. 1-23.
Kundrot, C.E. Which Strategy for a Protein Crystallization Project? Cellular Molecular Life Science. 2004. vol. 61, pp. 525-536.
Cudney R. Protein Crystallization and Dumb Luck. The Rigaku Journal. 1999. vol. 16, No. 1, pp. 1-7.
Drenth, “Principles of Protein X-Ray Crystallography”, 2nd Edition, 1999 Springer-Verlag New York Inc., Chapter 1, p. 1-21.
Ginalski et al., Comparative Modeling for Protein Structure Prediction. Current Opinion in Structural Biololgy, 2006. vol. 16, pp. 172-177.
Franzoni et al., “Structure of two fragments of the third cytoplasmic loop of the rat angiotensin II AT1A receptor: Implications with respect to receptor activation and G-protein selection and coupling,”J. of Biological Chem., 274:227-235, 1999.
Pellegrini et al., “Structural characterization of peptide hormone/receptor interactions by nmr spectroscopy,”Bioplymers, 51:208-209, 212, 217, 1999.
Terstappen et al, “In Silico Research in Drug Discovery,”Trends in Pharmacological Sciences, 22:23-26, 2001.
Yeagle et al., “Studies on the structure of the G-protein-coupled receptor rhodopsin including the putative G-protein binding site in unactivated and activated forms,”Biochemistry, 40:11932-11937, 2001.
Bugg et al., “Drugs by design,”Scientific American, 92-98, 1993.
Dautzenberg et al., “Binding differences of human and amphibian corticotropin-releasing factor type 1 (CRF(1)) receptors: identification of amino acids mediating high-affinity astressin binding and functional antagonism,”Regul. Pept., 118: 165-173, 2004.
Dautzenberg et al., “Five amino acids of theXenopus laevisCRF (corticotropin-releasing factor) type 2 receptor mediate differential binding of CRF ligands in comparison with its human counterpart,”Mol. Pharmacol., 61: 1132-1139, 2002.
Furth et al., “Temporal control of gene expression in transgenic mice by a tetracycline-responsive promoter,”Proc. Natl. Acad. Sci. USA, 91: 9302-9306, 1994.
George et al., “Mutation data matrix and its uses,”Methods Enzymol, 183: 333-351, 1990.
Gossen et al., “Tight control of gene expression in mammalian cells by tetracycline-responsive promoters,”Proc. Natl. Acad. Sci. USA, 89: 5547-5551, 1992.
Gossen et al., “Transcriptional activation by tetracyclines in mammalian cells,”Science, 268: 1766-1769, 1995.
Grace et al., “NMR structure and peptide hormone binding site of the first extracellular domain of a type B1 G protein-coupled receptor,”Proc. Natl. Acad. Sci. USA, 101(35): 12836-12841, 2004.
Hackeng et al., “Protein synthesis by native chemical ligation: expanded scope by using straightforward methodology,”Proc. Natl. Acad. Sci. USA, 96: 10068-10073, 1999.
Johnson et al., “A structural basis for sequence comparisons. An evaluation of scoring methodologies,”J. Mol. Biol., 233(4): 716-738, 1993.
Kawashima and Kanehisa, “AAindex: amino acid index database,”Nucleic Acids Res., 28(1): 374, 2000.
No et al., “Ecdysone-inducible gene expression in mammalian cells and transgenic mice,”Proc. Natl. Acad. Sci. USA, 93: 3346-3351, 1996.
Perrin et al., “A soluble form of the first extracellular domain of mouse type 2beta corticotropin-releasing factor receptor reveals differential ligand specificity,”J. Biol. Chem., 278: 15595-600, 2003.
Riek et al., “Evolutionary conservation of both the hydrophilic and hydrophobic nature of transmembrane residues,”J. Theor. Biol., 172: 245-258, 1995.
Szabo et al., “Surface plasmon resonance and its use in biomolecular interaction analysis (BIA),”Curr. Opin. Struct. Biol, 5: 699-705, 1995.
West et al., “Targeting HIV-1 protease: a test of drug-design methodologies,”Trends Pharmacol. Sci., 16(2): 67-75, 1995.
Wille et al., “Identification of amino acids in the N-terminal domain of corticotropin-releasing factor receptor 1 that are important determinants of high-affinity ligand binding,”J. Neurochem., 72: 388-395, 1999.
Perrin Marilyn H.
Riek Roland
Rivier Jean E.
Royappa Grace Christy Rani
Vale, Jr. Wylie W.
Fulbright & Jaworski L.L.P.
Noakes Suzanne M.
Research Development Foundation
LandOfFree
Structure-based modulators of B1 G-protein coupled receptors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Structure-based modulators of B1 G-protein coupled receptors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Structure-based modulators of B1 G-protein coupled receptors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2705073